Lista de obras - Laurence Fenart - Dominio Público Uruguay

A New Function for the LDL Receptor: Transcytosis of LDL across the Blood–Brain Barrier ⬇️

artículo científico publicado el 25 de agosto de 1997

A differential proteomic approach identifies structural and functional components that contribute to the differentiation of brain capillary endothelial cells.

artículo científico publicado en 2011

A large-scale electrophoresis- and chromatography-based determination of gene expression profiles in bovine brain capillary endothelial cells after the re-induction of blood-brain barrier properties ⬇️

artículo científico publicado el 15 de noviembre de 2010

Abstracts from the 20th International Symposium on Signal Transduction at the Blood-Brain Barriers.

artículo científico publicado en 2017

Amyloid-β peptides, Alzheimer's disease and the blood-brain barrier.

artículo científico publicado en 2013

An in vitro blood-brain barrier model for high throughput (HTS) toxicological screening.

artículo científico publicado en 2008

Apical-to-basolateral transport of amyloid-β peptides through blood-brain barrier cells is mediated by the receptor for advanced glycation end-products and is restricted by P-glycoprotein

artículo científico publicado en 2010

Astrocytes are mainly responsible for the polyunsaturated fatty acid enrichment in blood-brain barrier endothelial cells in vitro ⬇️

artículo científico publicado el 1 de septiembre de 1998

Behavior of alpha-, beta-, and gamma-cyclodextrins and their derivatives on an in vitro model of blood-brain barrier.

artículo científico publicado en 2004

Bexarotene Promotes Cholesterol Efflux and Restricts Apical-to-Basolateral Transport of Amyloid-β Peptides in an In Vitro Model of the Human Blood-Brain Barrier

artículo científico publicado en 2015

Brain pericytes ABCA1 expression mediates cholesterol efflux but not cellular amyloid-β peptide accumulation.

artículo científico publicado en 2012

Cerebrovascular protection as a possible mechanism for the protective effects of NXY-059 in preclinical models: an in vitro study.

artículo científico publicado en 2009

Contribution of glial cells and pericytes to the mRNA profiles of P-glycoprotein and multidrug resistance-associated proteins in an in vitro model of the blood-brain barrier

artículo científico publicado en 2004

Cyclodextrins as Emerging Therapeutic Tools in the Treatment of Cholesterol-Associated Vascular and Neurodegenerative Diseases

artículo científico publicado en 2016

Down-regulation of caveolin-1 in glioma vasculature: modulation by radiotherapy.

artículo científico publicado en 2004

Effects of gamma- and hydroxypropyl-gamma-cyclodextrins on the transport of doxorubicin across an in vitro model of blood-brain barrier.

artículo científico publicado en 2004

Effects of oxysterols on the blood-brain barrier: implications for Alzheimer's disease.

artículo científico publicado en 2013

Efficient Docosahexaenoic Acid Uptake by the Brain from a Structured Phospholipid.

artículo científico publicado en 2015

Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier

artículo científico publicado en 1999

High transcytosis of melanotransferrin (P97) across the blood-brain barrier

artículo científico publicado en 2002

In vitro discrimination of the role of LRP1 at the BBB cellular level: focus on brain capillary endothelial cells and brain pericytes

artículo científico publicado en 2014

In vitro models for the blood-brain barrier.

artículo científico publicado en 2005

Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicity

artículo científico publicado en 1999

Inhibition of P-glycoprotein: rapid assessment of its implication in blood-brain barrier integrity and drug transport to the brain by an in vitro model of the blood-brain barrier.

artículo científico publicado en 1998

Modelling of the blood-brain barrier in drug discovery and development.

artículo científico publicado en 2007

Modelling the neurovascular unit and the blood-brain barrier with the unique function of pericytes.

artículo científico publicado en 2011

Monoacylation of ribonuclease A enables its transport across an in vitro model of the blood-brain barrier.

artículo científico publicado en 1998

Mouse syngenic in vitro blood-brain barrier model: a new tool to examine inflammatory events in cerebral endothelium.

artículo científico publicado en 2005

Oxysterols decrease apical-to-basolateral transport of Aß peptides via an ABCB1-mediated process in an in vitro Blood-brain barrier model constituted of bovine brain capillary endothelial cells.

artículo científico publicado en 2013

P-glycoprotein in blood-brain barrier endothelial cells: interaction and oligomerization with caveolins.

artículo científico publicado en 2003

Peroxisome-proliferator-activated receptor-alpha activation protects brain capillary endothelial cells from oxygen-glucose deprivation-induced hyperpermeability in the blood-brain barrier.

artículo científico publicado en 2009

Physiological pathway for low-density lipoproteins across the blood-brain barrier: transcytosis through brain capillary endothelial cells in vitro.

artículo científico publicado en 2008

Prediction of drug transport through the blood-brain barrier in vivo: a comparison between two in vitro cell models.

artículo científico publicado en 2002

Preferential transfer of 2-docosahexaenoyl-1-lysophosphatidylcholine through an in vitro blood-brain barrier over unesterified docosahexaenoic acid.

artículo científico publicado en 1999

Protein transport in cerebral endothelium. In vitro transcytosis of transferrin.

artículo científico publicado en 2003

Receptor-mediated transcytosis of cyclophilin B through the blood-brain barrier.

artículo científico publicado en 1999

Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier.

artículo científico publicado en 1999

Resveratrol and Grape Extract-loaded Solid Lipid Nanoparticles for the Treatment of Alzheimer's Disease

artículo científico publicado en 2017

Stroke-induced brain parenchymal injury drives blood-brain barrier early leakage kinetics: a combined in vivo/in vitro study.

artículo científico publicado en 2013

The MAP kinase pathway mediates transcytosis induced by TNF-alpha in an in vitro blood-brain barrier model

artículo científico publicado en 2005

Transcriptional profiles of receptors and transporters involved in brain cholesterol homeostasis at the blood-brain barrier: use of an in vitro model.

artículo científico publicado en 2008

Transport of cationized anti-tetanus Fab'2 fragments across an in vitro blood-brain barrier model: involvement of the transcytosis pathway

artículo científico publicado en 1999

Transport screening of drug cocktails through an in vitro blood-brain barrier: is it a good strategy for increasing the throughput of the discovery pipeline?

artículo científico publicado en 2004

[Cerebral transfer and neuroprotection]

artículo científico publicado en 2004

[Role of the blood-brain barrier in Alzheimer's disease]

scientific article published on 30 November 2011

β-Cyclodextrins Decrease Cholesterol Release and ABC-Associated Transporter Expression in Smooth Muscle Cells and Aortic Endothelial Cells

artículo científico publicado en 2016

Lista de obras de Laurence Fenart

A New Function for the LDL Receptor: Transcytosis of LDL across the Blood–Brain Barrier ⬇️

A differential proteomic approach identifies structural and functional components that contribute to the differentiation of brain capillary endothelial cells.

A large-scale electrophoresis- and chromatography-based determination of gene expression profiles in bovine brain capillary endothelial cells after the re-induction of blood-brain barrier properties ⬇️

Abstracts from the 20th International Symposium on Signal Transduction at the Blood-Brain Barriers.

Amyloid-β peptides, Alzheimer's disease and the blood-brain barrier.

An in vitro blood-brain barrier model for high throughput (HTS) toxicological screening.

Apical-to-basolateral transport of amyloid-β peptides through blood-brain barrier cells is mediated by the receptor for advanced glycation end-products and is restricted by P-glycoprotein

Astrocytes are mainly responsible for the polyunsaturated fatty acid enrichment in blood-brain barrier endothelial cells in vitro ⬇️

Behavior of alpha-, beta-, and gamma-cyclodextrins and their derivatives on an in vitro model of blood-brain barrier.

Bexarotene Promotes Cholesterol Efflux and Restricts Apical-to-Basolateral Transport of Amyloid-β Peptides in an In Vitro Model of the Human Blood-Brain Barrier

Brain pericytes ABCA1 expression mediates cholesterol efflux but not cellular amyloid-β peptide accumulation.

Cerebrovascular protection as a possible mechanism for the protective effects of NXY-059 in preclinical models: an in vitro study.

Contribution of glial cells and pericytes to the mRNA profiles of P-glycoprotein and multidrug resistance-associated proteins in an in vitro model of the blood-brain barrier

Cyclodextrins as Emerging Therapeutic Tools in the Treatment of Cholesterol-Associated Vascular and Neurodegenerative Diseases

Down-regulation of caveolin-1 in glioma vasculature: modulation by radiotherapy.

Effects of gamma- and hydroxypropyl-gamma-cyclodextrins on the transport of doxorubicin across an in vitro model of blood-brain barrier.

Effects of oxysterols on the blood-brain barrier: implications for Alzheimer's disease.

Efficient Docosahexaenoic Acid Uptake by the Brain from a Structured Phospholipid.

Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier

High transcytosis of melanotransferrin (P97) across the blood-brain barrier

In vitro discrimination of the role of LRP1 at the BBB cellular level: focus on brain capillary endothelial cells and brain pericytes

In vitro models for the blood-brain barrier.

Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicity

Inhibition of P-glycoprotein: rapid assessment of its implication in blood-brain barrier integrity and drug transport to the brain by an in vitro model of the blood-brain barrier.

Modelling of the blood-brain barrier in drug discovery and development.

Modelling the neurovascular unit and the blood-brain barrier with the unique function of pericytes.

Monoacylation of ribonuclease A enables its transport across an in vitro model of the blood-brain barrier.

Mouse syngenic in vitro blood-brain barrier model: a new tool to examine inflammatory events in cerebral endothelium.

Oxysterols decrease apical-to-basolateral transport of Aß peptides via an ABCB1-mediated process in an in vitro Blood-brain barrier model constituted of bovine brain capillary endothelial cells.

P-glycoprotein in blood-brain barrier endothelial cells: interaction and oligomerization with caveolins.

Peroxisome-proliferator-activated receptor-alpha activation protects brain capillary endothelial cells from oxygen-glucose deprivation-induced hyperpermeability in the blood-brain barrier.

Physiological pathway for low-density lipoproteins across the blood-brain barrier: transcytosis through brain capillary endothelial cells in vitro.

Prediction of drug transport through the blood-brain barrier in vivo: a comparison between two in vitro cell models.

Preferential transfer of 2-docosahexaenoyl-1-lysophosphatidylcholine through an in vitro blood-brain barrier over unesterified docosahexaenoic acid.

Protein transport in cerebral endothelium. In vitro transcytosis of transferrin.

Receptor-mediated transcytosis of cyclophilin B through the blood-brain barrier.

Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier.

Resveratrol and Grape Extract-loaded Solid Lipid Nanoparticles for the Treatment of Alzheimer's Disease

Stroke-induced brain parenchymal injury drives blood-brain barrier early leakage kinetics: a combined in vivo/in vitro study.

The MAP kinase pathway mediates transcytosis induced by TNF-alpha in an in vitro blood-brain barrier model

Transcriptional profiles of receptors and transporters involved in brain cholesterol homeostasis at the blood-brain barrier: use of an in vitro model.

Transport of cationized anti-tetanus Fab'2 fragments across an in vitro blood-brain barrier model: involvement of the transcytosis pathway

Transport screening of drug cocktails through an in vitro blood-brain barrier: is it a good strategy for increasing the throughput of the discovery pipeline?

[Cerebral transfer and neuroprotection]

[Role of the blood-brain barrier in Alzheimer's disease]

β-Cyclodextrins Decrease Cholesterol Release and ABC-Associated Transporter Expression in Smooth Muscle Cells and Aortic Endothelial Cells